Cytodyne Technologies, Inc. v. Biogenic Technologies, Inc.

216 F.R.D. 533, 2003 U.S. Dist. LEXIS 14694, 2003 WL 21489899
CourtDistrict Court, M.D. Florida
DecidedJune 4, 2003
DocketNo. 3:03-MC-4-J-TEM
StatusPublished
Cited by10 cases

This text of 216 F.R.D. 533 (Cytodyne Technologies, Inc. v. Biogenic Technologies, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cytodyne Technologies, Inc. v. Biogenic Technologies, Inc., 216 F.R.D. 533, 2003 U.S. Dist. LEXIS 14694, 2003 WL 21489899 (M.D. Fla. 2003).

Opinion

ORDER

MORRIS, United States Magistrate Judge.

This ease came before the Court on April 30, 2003 for a hearing on Defendant Super Natural Distributors, Inc.’s Motion for Order Compelling Compliance with Subpoena (Doc. # 1, Motion to Compel), Non-party Tree of Life’s Response to Motion for Order Compelling Compliance with Subpoena and Cross-Motion to Quash with Incorporated Memorandum of Law (Doc. # 5, Motion to Quash) and Super Natural Distributors, Inc.’s Motion to Expedite Ruling on Motion for Order Compelling Compliance with Subpoena (Doc #6, Motion to Expedite). All counsel of record known to this Court were notified of the motion hearing. Only counsel for Defendant Super Natural Distributors Inc. and non-party Tree of Life attended the hearing. Oral argument was heard from counsel present at the hearing.

Super Natural Distributors, Inc. (“Super Natural”) is a named defendant in the lawsuit currently pending in the United States District Court for the District of New Jersey that underlies this miscellaneous case. Cyto-dyne Technologies, Inc. is the plaintiff in the New Jersey action. On September 5, 2002, Super Natural issued a subpoena to non-party Tree of Life for a “designated witness” deposition and production of records wherein numerous records concerning Tree of Life’s business in general and business dealings with Cytodyne Technologies, Inc. in particular were requested. (See Doc. # 5, Ex. D for copy of subpoena.1) This request for third party discovery arose out of Super Natural’s counterclaim for price discrimination against Plaintiff Cytodyne Technologies (Doc. # 1 at 1). Tree of Life objects to the subpoena on the grounds it seeks trade secret and proprietary information that if disclosed would give Defendant Super Natural2 a competitive advantage and that Defendant has failed to meet its burden establishing that the information sought is relevant and necessary to its lawsuit (Doc. # 5, pp. 6-17). Both parties acknowledge that Tree of Life, Inc. and Super Natural Distributors, Inc. are competitors in the marketplace (Doc. # 2 at 3; Doc. # 5 at 3).

The subpoena at issue called for the production of documents in Milwaukee, Wisconsin3 on September 12, 2002 and the appearance of a corporate representative in Jacksonville, Florida for a deposition on September 16, 2002 (Doc. #2, p. 3). The subpoena seeks deposition testimony on the following subjects:

1. The relationship between Tree of Life, Inc. d/b/a Forcite/The Source (“Forcite”) and Cytodyne Technologies, Inc. (“Cyto-dyne”) including, without limitation, the prices Cytodyne charge Forcite for products manufactured by or on behalf of Cyto-dyne (“Cytodyne Products”), the quantity of Cytodyne Products Forcite purchased from Cytodyne, and other terms of sale.
2. Any departure from the standard prices or terms of sale offered to Forcite by Cytodyne in connection with transactions involving or relating to Foreite’s purchase of Cytodyne Products from Cyto-dyne.
3. Arrangements and agreements between Forcite and Cytodyne concerning prices and terms of sale.
[535]*5354. Rebates, credits, premiums, free product, or any other type of price reduction or discount that Cytodyne offered and/or provided to Forcite in connection with transactions involving or relating to Foreite’s purchase of Cytodyne Products from Cyto-dyne.
5. The terms of sale, including the price and quantity of product, for Cytodyne Products sold by Forcite to its customers during the time period October 1998 to March 2001.
6. Forcite’s policies and practices concerning resale pricing on Cytodyne Products and any variations in such pricing.
7. The geographic areas in which, and the classes of trade to which, Forcite resold Cytodyne Products.
8. Oral and written communications between Forcite and Cytodyne concerning pricing and resale pricing during the period from January 1998 through December 2000.

(Doc. # 1, p. 2; Doc. # 5, Ex. D, Subpoena, Schedule A.)

Super Natural seeks documents for inspection and copying concerning:

1. Invoices, credit memos, and corresponding payment records, including, but not limited to cheeks, wire transfers and/or rebates vouchers, reflecting or relating to the sale of Cytodyne Products by Forcite to its customers for the time period October 1998 to March 2001.
2. Invoices, credit memos, and corresponding payment records, including, but not limited to checks, wire transfers and/or rebates vouchers, from Cytodyne to For-cite reflecting or relating to the purchase of Cytodyne Products by Forcite for the time period October 1998 to March 2001.

(Doc. # 1, p. 3; Doe. # 5, Ex. D, Subpoena Schedule B.)

Discussion

Motions to compel disclosures and other discovery are committed to the sound discretion of the trial court. Commercial Union Insurance Co. v. Westrope, 730 F.2d 729, 731 (11th Cir.1984). The scope of discovery under the Federal Rules is broad. “Parties may obtain discovery of any matter, not privileged, which is relevant to the subject matter involved in the pending action ....” FED. R. CIV. P. 26(b). The Supreme Court has held that discovery is designed to help define and clarify the issues. Hickman v. Taylor, 329 U.S. 495, 501, 67 S.Ct. 385, 91 L.Ed. 451 (1947).

Although Rule 26(b) applies to discovery of non-parties as well as parties in a suit, non-party status is considered by the court in weighing the burdens imposed in providing the requested discovery. See American Standard Inc. v. Pfizer Inc., 828 F.2d 734 (Fed.Cir.1987) (affirming district court’s restriction of discovery where non-party status “weigh[ed] against disclosure”); American Electric Power Company, Inc. v. United States, 191 F.R.D. 132, 136 (S.D.Oh. 1999) (status as a non-party is a factor that weighs against disclosure); Solarex Corp. v. Arco Solar, Inc., 121 F.R.D. 163, 179 (E.D.N.Y.1988) (non-party status is a significant factor in determining whether discovery is unduly burdensome). The limited case law in this area reveals a ease-specific balancing test wherein the court must weigh factors such as relevance, the need of the party for the documents, the breadth of the document request, and the time period covered by the request against the burden imposed on the person ordered to produce the desired information. Farnsworth v. Procter & Gamble Company, 758 F.2d 1545 (11th Cir.1985); American Electric Power Company, Inc. v. United States, 191 F.R.D. 132 (S.D.Oh.1999). Further, the courts have acknowledged that disclosure of confidential information to a competitor is presumed to be harmful to the disclosing entity. See American Standard, Inc., 828 F.2d at 741 and cases cited therein.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
216 F.R.D. 533, 2003 U.S. Dist. LEXIS 14694, 2003 WL 21489899, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cytodyne-technologies-inc-v-biogenic-technologies-inc-flmd-2003.